SRS Investment Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-169,741
Closed -$2.84M 26
2022
Q4
$2.84M Hold
169,741
0.05% 20
2022
Q3
$2.91M Hold
169,741
0.06% 20
2022
Q2
$1.33M Hold
169,741
0.03% 22
2022
Q1
$1.88M Hold
169,741
0.02% 30
2021
Q4
$2.98M Hold
169,741
0.04% 24
2021
Q3
$3.44M Hold
169,741
0.05% 25
2021
Q2
$5.61M Hold
169,741
0.08% 25
2021
Q1
$6.63M Hold
169,741
0.1% 27
2020
Q4
$7.41M Buy
+169,741
New +$5.8M 0.12% 28

SRS Investment Management's ONEM Position: Q1 2023 in Review

SRS Investment Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 169,741 shares — an estimated $2.84M sold.

SRS Investment Management first reported a position in ONEM in Q4 2020 and held it in 9 quarters. The position peaked at $7.41M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • SRS Investment Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • SRS Investment Management sold 169,741 1Life Healthcare shares in Q1 2023, an estimated $2.84M.
  • SRS Investment Management first reported a position in 1Life Healthcare in Q4 2020 and held it in 9 quarters.
  • SRS Investment Management's 1Life Healthcare position peaked at $7.41M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on SRS Investment Management's 13F filing for Q1 2023, filed 15 May 2023.